Japan Intellectual Property Rights: ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR TREATMENT OF DISEASE

Japan, Aug. 6 -- PETRA PHARMA CORP has got intellectual property rights for 'ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR TREATMENT OF DISEASE.' Other related details are as follows:

Application Number: JP,2023-186956

Category (FI): A61K31/497,C07D493/08,C07D487/04,138,C07D417/14,A61K31/5383,C07D498/04,111,C07D513/04,301,C07D498/04,101,A61K31/5377,A61K31/416,A61K31/4439,C07D413/14,C07D491/056,C07D413/12,A61K31/517,A61K31/4245,A61K31/4433,C07D405/12,C07D405/04,C07D405/14,A61K31/444,C07D471/04,106@C,A61P35/02,A61P35/00,A61P43/00,111,C07D491/048,A61K31/506,C07D471/04,113,A61K31/4709,C07D487/04,142,C07D471/04,106@A,A61K31/5365,A61K31/4725,C07D471/04,108@A,A61K31/498

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 31, 2023

Publication Date: May 15, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.